(RTTNews) - Glenmark Pharmaceuticals Inc., USA (GLENMARK.NS), Thursday announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.

Glenmark Pharmaceuticals on Tuesday, January 21, said its US arm has launched Phytonadione Injectable Emulsion USP, 10mg/ml ...

Glenmark Pharmaceuticals on Tuesday said its US arm has launched anticoagulant Phytonadione injectable emulsion.   Glenmark ...

The uptick in Glenmark Pharmaceuticals share price came after the company announced the launch of Phytonadione Injectable ...

A healthy, term, newborn boy erroneously received adult-strength phytonadione injectable emulsion 10 mg/mL at a dose of 5 mg/0.5 mL administered intramuscularly into his right thigh at 3 hours of ...

Glenmark launches phytonadione injectable emulsion USP, 10 mg/mL single dose ampules: Our Bureau, Mumbai Tuesday, January 21, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., ...

It further said that the single-dose ampules are both bioequivalent and therapeutically equivalent to the reference listed ...

According to IQVIATM sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market 2 achieved annual sales of approximately $19.7 million*.

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.